StratifAI

Our latest research featured on the Oncology Learning Network! 🎤 In this interview, our CEO Omar El Nahhas speaks about StratifAI BReast (SAIBR), a novel AI-based prognostication method predicting long-term progression-free survival in HR+/HER2- early breast cancer. 🧬 Our exciting results were accepted as late-breaking abstract at #SABCS2024. However, this is just the beginning - we are initially developing these tools in breast cancer, but are expanding to other solid tumor cancers to improve prognostication and help steer better treatment decisions, worldwide! 🌍💜 Check the video in the link below. 👇 https://lnkd.in/gZ2W4kdY

Europe Startup Watch - November 2024 This month, we spotlight 4 fantastic startups creating the future across technology! StratifAI Arkeon Koios AI Autonomous Minds With funding rounds ranging from €50K to €4M, these early-stage startups are positioned for massive growth and market impact!

StratifAI selected as Vestbee/HubSpot start-up of the month, chosen from 1000+ participants! 🥳 Want to become part of our mission to develop the next generation of biomarkers to improve cancer patient outcomes? Good news, we're hiring! 🚀 Will you be our next Product Manager, Quality Manager, Head of Operations, Machine Learning Engineer, Cloud Infrastructure Engineer or Senior Full-Stack Engineer? Read more and apply through our website https://lnkd.in/gQ5JxenE, or directly send your CV to careers@stratifai.com.

🚀 ❄️ Vestbee's Winter Pitch powered by HubSpot has wrapped up, and it was a pleasure to partner with the team once again in supporting innovative #startups across Europe! 👏🏽 A big congratulations to the top 10 finalists: StratifAI, Koios, Cargofy, Autonomous Minds, Spendbase, Salesforge 🔥, FleetFox, Banani, UncovAI, and Motics selected by a wide panel of European VC representatives, including our Investment Manager Veronika A.! #innovation #pitching #europeanstartups #venturecapital #vc

🔥 Vestbee Winter Pitch powered by HubSpot has officially come to an end! We want to take a moment to thank everyone who participated and supported this initiative! Congratulations to the TOP 10 🏆  finalists - meet the exceptional European startups: StratifAI, Koios, Cargofy, Autonomous Minds, Spendbase, Salesforge 🔥, FleetFox, Banani, UncovAI, Motics 👩⚖️We deeply appreciate the contribution of our esteemed Judges. Thank you to: Ewa Chronowska from Vestbee Bakhrom I. from Molten Ventures Pedro Santos Vieira from 500 Global Valeri Petrov from Eleven Ventures Marton Medveczky from Flashpoint Venture Capital Marcin Hejka from OTB Ventures Tomas Pacinda from KAYA VC Jakob Stein from Creandum Elena M. from Flyer One Ventures Maximilian Schausberger from Elevator Ventures Yvan-Michel Ehkirch from Karista Henric Hungerhoff from HEARTFELT_ ... Special thanks to all initiative Participants, Partners, and a big thank you goes to HubSpot - this initiative wouldn’t be the same without your support! Want to participate in events like the Vestbee Winter Pitch? Join Vestbee to stay informed about our latest initiatives and connect with fundraising startups. Complete this quick form:  ➡️https://lnkd.in/dQzXWVCH 

🚨 Exciting news from the San Antonio Breast Cancer Symposium 2024! Our deep learning model, StratifAI BReast (SAIBR), achieves a breakthrough in early-stage HR+/HER2- breast cancer prognosis. Using only H&E-stained histology resections, SAIBR was significantly associated with 12-year progression-free survival risk, adjusted for factors including age, nodal status, tumor stage, adjuvant chemotherapy administration, and the molecular risk of recurrence. 🔬 Join us at our late-breaking poster session (P2-06-18)! Meet CEO Omar El Nahhas and CTO Firas Khader to discover how our AI-based spatial biomarkers: • Enhance stratification of existing cancer drugs • Accelerate cancer drug discovery R&D 👏 Congratulations to the co-authors Omar El Nahhas, Firas Khader, Pavol Cekan, Evan Paul, Nicoleta Antone, Daniel Truhn, Jakob Nikolas Kather! #SABCS2024 #breastcancer #earlystage #recurrencerisk #precisiononcology #deeplearning #tumormicroenvironment #biomarkers #startup #techbio #healthtech #VC #drugdiscovery #stratification

🚀 New tech publication from StratifAI! 🚀 We presented our latest research work, selected for oral presentation, at one of the largest medical imaging conferences in the world, #MICCAI2024 🤩 In this technical research paper, we show improvements beyond the current state of the art in predicting relevant cancer biomarkers which are predictive of treatment response using deep learning in pathology 🔬 Check out the full paper below 👇 https://lnkd.in/gG_a24eS #cancer #oncology #treatment #biomarkers #pathology #deeplearning #medicalimaging #StratifAI #paper #cancerresearch #artificialintelligence #precisiononcology #MSI #HRD #immunotherapy #PARPi

We are excited to announce our participation in the NVIDIA Inception Program! This program is designed to assist startups in rapid growth, providing a variety of resources ranging from computing power to access to investor networks, allowing us to accelerate our development of state-of-the-art deep learning models for precision oncology. 🚀 #NVIDIAInception #StratifAI #PrecisionOncology #AIStartup #cancer #biomarkers #deeplearning #VC #AWS #NVIDIA #GPU #cloud

🚀 Exciting news! StratifAI has been selected as one of the top 10 finalists to pitch in the "Cancer Care" track of Health Tech Challengers 2024 in Barcelona! A huge thank you to our amazing team and supporters! 🙌 We’re looking forward to sharing our vision for the next generation of biomarkers for precision oncology. #precisiononcology #deeplearning #biomarkers #prognostication #pitch #startup #challenges #deeptech

🚀 New Nature Portfolio publication from StratifAI! 🚀 We’re pleased to announce that our latest paper, "From whole-slide image to biomarker prediction: end-to-end weakly supervised deep learning in computational pathology", has been published in Nature Protocols! 🎉 The protocol sets the standard for executing computational pathology projects, providing a step-by-step workflow that bridges the gap between clinical researchers and engineers. It is designed to streamline the prediction of biomarkers directly from whole-slide images, making it an invaluable tool for precision oncology. At StratifAI, we’re leading the way in this rapidly evolving field. While this protocol establishes a solid foundation, we’re developing more advanced models and techniques to push the boundaries of what’s possible in computational pathology. Stay tuned for more innovations as we continue to enhance precision oncology through cutting-edge AI technology. 💡 🔗 Read the full protocol here: https://lnkd.in/gpc5BzY6 #AI #DeepLearning #ComputationalPathology #Innovation #CancerResearch #StratifAI